Farther Finance Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
IA
MCI
HNB
Farther Finance Advisors's AMED Position: Q3 2025 in Review
Farther Finance Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 59 shares — an estimated $5.8K sold.
Farther Finance Advisors first reported a position in AMED in Q4 2022 and held it in 11 quarters. The position peaked at $8.88K in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Farther Finance Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Farther Finance Advisors sold 59 Amedisys shares in Q3 2025, an estimated $5.8K.
- Farther Finance Advisors first reported a position in Amedisys in Q4 2022 and held it in 11 quarters.
- Farther Finance Advisors's Amedisys position peaked at $8.88K in Q3 2024.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Farther Finance Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.